Alexa Michel

Also affiliated with Massachusetts General Hospital

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 11 papers. Top paper: “Combined PD-1, BRAF and MEK inhibition in BRAFV600E colorectal cancer: a phase 2 trial”.

Combined PD-1, BRAF and MEK inhibition in BRAFV600E colorectal cancer: a phase 2 trial

Nature Medicine(2023)10.1038/s41591-022-02181-8

N/A

4.9DataRank · unranked

192 citations

Jonathan Chen, Sherry Chao, Karin Pelka, Marios Giannakis, Julian M. Hess +40 more

Cell-Free HPV DNA Provides an Accurate and Rapid Diagnosis of HPV-Associated Head and Neck Cancer

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-21-3151

N/A

0DataRank · unranked

114 citations

Connor J. O'Boyle, Shohreh Varmeh, Natalia Queenan, Alexa Michel, Jarrod Stein +22 more

Cell‐free human papillomavirus DNA kinetics after surgery for human papillomavirus–associated oropharyngeal cancer

Cancer(2022)10.1002/cncr.34109

N/A

0DataRank · unranked

83 citations

Giulia Siravegna, Shohreh Varmeh, Natalia Queenan, Alexa Michel, Kim Chang Sing Pang +19 more

Incidence and management of esophageal cancer recurrence to regional lymph nodes after curative esophagectomy

International Journal of Cancer(2022)10.1002/ijc.34417

N/A

0DataRank · unranked

29 citations

Rebecca Carr, Meier Hsu, Alexa Michel, Kay See Tan, Elvira L. Vos +7 more

Landscape of Clinical Resistance Mechanisms to FGFR Inhibitors in FGFR2-Altered Cholangiocarcinoma

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-23-1317

N/A

0DataRank · unranked

80 citations

Haley Ellis, Giulia Siravegna, Alexa Michel, Bryanna L. Norden, Ferran Fece de la Cruz +7 more

212Pb-Pretargeted Theranostics for Pancreatic Cancer

Journal of Nuclear Medicine(2023)10.2967/jnumed.123.266388

N/A

0DataRank · unranked

44 citations

Lukas M. Carter, Mohamed I. Atmane, Roberto De Gregorio, Alexa Michel, Spencer Kaminsky +5 more

Shifting the Antibody–Drug Conjugate Paradigm: A Trastuzumab-Gold-Based Conjugate Demonstrates High Efficacy against Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer Mouse Model

ACS Pharmacology & Translational Science(2023)10.1021/acsptsci.3c00270

N/A

0DataRank · unranked

5 citations

Hiwa K. Saeed, Virginia del Solar, Javier E. López‐Hernández, Alexa Michel, Joshua Mathew +3 more

Phase I/II Study of Combined BCL-xL and MEK Inhibition with Navitoclax and Trametinib in KRAS or NRAS Mutant Advanced Solid Tumors

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-23-3135

N/A

0DataRank · unranked

36 citations

T. Khanh, Jeong Eun Kim, James M. Cleary, Aparna R. Parikh, Oladapo Yeku +26 more

Examination of the PET in vivo generator 134Ce as a theranostic match for 225Ac

European Journal of Nuclear Medicine and Molecular Imaging(2024)10.1007/s00259-024-06811-w

N/A

0DataRank · unranked

10 citations

R. De Gregorio, Edwin C. Pratt, A. J. Bell, Alexa Michel, Jason S. Lewis +1 more

Clinical Acquired Resistance to KRASG12C Inhibition through a Novel KRAS Switch-II Pocket Mutation and Polyclonal Alterations Converging on RAS–MAPK Reactivation

Cancer Discovery(2021)10.1158/2159-8290.cd-21-0365

N/A

0DataRank · unranked

520 citations

W. Marston Linehan, Chendi Li, Meagan B. Ryan, Junbing Zhang, Lesli A. Kiedrowski +15 more

Exploring the PET in vivo generator 134 Ce as a theranostic match for 225 Ac

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.04.25.591165

N/A

0DataRank · unranked

0 citations

R. De Gregorio, Edwin C. Pratt, A. J. Bell, Alexa Michel, Jason S. Lewis +1 more